Psychoactive Drugs Stocks List

Recent Signals

Date Stock Signal Type
2021-03-03 AVDL Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-03 AVDL NR7 Range Contraction
2021-03-03 AZN Lower Bollinger Band Walk Weakness
2021-03-03 BDL Narrow Range Bar Range Contraction
2021-03-03 BXRX 50 DMA Resistance Bearish
2021-03-03 CLVR Fell Below 20 DMA Bearish
2021-03-03 CMPS Fell Below 50 DMA Bearish
2021-03-03 CMPS 20 DMA Resistance Bearish
2021-03-03 KMPH Volume Surge Other
2021-03-03 KMPH Pocket Pivot Bullish Swing Setup
2021-03-03 KMPH Parabolic Rise Strength
2021-03-03 KMPH MACD Bullish Signal Line Cross Bullish
2021-03-03 KMPH Gilligan's Island Sell Setup Bearish Swing Setup
2021-03-03 KMPH Wide Range Bar Range Expansion
2021-03-03 NEOS Fell Below 50 DMA Bearish
2021-03-03 NEOS MACD Bearish Centerline Cross Bearish
2021-03-03 NERV 50 DMA Support Bullish
2021-03-03 NERV Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-03 NERV MACD Bearish Centerline Cross Bearish
2021-03-03 NERV Lower Bollinger Band Walk Weakness
2021-03-03 OYST NR7 Range Contraction
2021-03-03 OYST 50 DMA Support Bullish
2021-03-03 SNDL Narrow Range Bar Range Contraction
2021-03-03 SWM NR7-2 Range Contraction
2021-03-03 SWM NR7 Range Contraction
2021-03-03 VLON New 52 Week Closing Low Bearish
2021-03-03 VLON New 52 Week Low Weakness
2021-03-03 VLON Narrow Range Bar Range Contraction
2021-03-03 VLON Hot IPO Pullback Bullish Swing Setup
2021-03-03 XXII Fell Below 50 DMA Bearish
2021-03-03 XXII Wide Range Bar Range Expansion
2021-03-03 ZYNE Narrow Range Bar Range Contraction

Recent News for Psychoactive Drugs Stocks

Date Stock Title
Mar 4 AQST ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - AQST
Mar 4 AZN AZN BREAKING ALERT: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline – AZN
Mar 3 AQST Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Aquestive Therapeutics, Inc. (AQST) on Behalf of Investors
Mar 3 AZN Lawsuits Filed Against AZN, XOM and EH - Jakubowitz Law Pursues Shareholders Claims
Mar 3 AQST INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Aquestive Therapeutics, Inc. (AQST) on Behalf of Investors
Mar 3 UVV Spotify Competitor Anghami To List On Nasdaq: What You Need To Know About The Music Streaming Platform
Mar 3 AZN COVID SCIENCE-T cell response to virus variants remains potent; Asthma does not raise severe COVID-19 risk
Mar 3 KMPH Mid-Afternoon Market Update: Nasdaq Falls Over 300 Points; Veritiv Shares Surge
Mar 3 AZN Doctor: Health care workers are ‘frustrated and concerned’ over lifting of virus mandates
Mar 3 AQST SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Mar 3 KMPH FUBO, RKT, TRXC and SOS among midday movers
Mar 3 KMPH KemPharm (KMPH) Soars on FDA Nod for ADHD Treatment, Azstarys
Mar 3 AZN Lifting restrictions without a fully vaccinated population is gambling: Doctor
Mar 3 AQST AQST INVESTOR LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Against Aquestive Therapeutics, Inc.
Mar 3 AZN HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts AstraZeneca (AZN) Investors to Securities Fraud Lawsuit Application Deadline, Encourages Investors Who Suffered Losses to Contact the Firm
Mar 3 AQST AQST BREAKING NEWS: ROSEN, A LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline – AQST
Mar 3 AZN Hungary to extend AstraZeneca jabs to people over 60, official says
Mar 3 AQST Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST)
Mar 3 XXII 22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual Property
Mar 3 VLON Vallon Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference

A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition, or behavior. These substances may be used medically; recreationally; to purposefully improve performance or alter one's consciousness; as entheogens; for ritual, spiritual, or shamanic purposes; or for research. Some categories of psychoactive drugs, which have therapeutic value, are prescribed by physicians and other healthcare practitioners. Examples include anesthetics, analgesics, anticonvulsant and antiparkinsonian drugs as well as medications used to treat neuropsychiatric disorders, such as antidepressants, anxiolytics, antipsychotics, and stimulant medications. Some psychoactive substances may be used in the detoxification and rehabilitation programs for persons dependent on or addicted to other psychoactive drugs.
Psychoactive substances often bring about subjective (although these may be objectively observed) changes in consciousness and mood that the user may find rewarding and pleasant (e.g., euphoria or a sense of relaxation) or advantageous (e.g. increased alertness) and are thus reinforcing. Substances which are both rewarding and positively reinforcing have the potential to induce a state of addiction – compulsive drug use despite negative consequences. In addition, sustained use of some substances may produce physical or psychological dependence or both, associated with somatic or psychological-emotional withdrawal states respectively. Drug rehabilitation attempts to reduce addiction, through a combination of psychotherapy, support groups, and other psychoactive substances. Conversely, certain psychoactive drugs may be so unpleasant that the person will never use the substance again. This is especially true of certain deliriants (e.g. Jimson weed), powerful dissociatives (e.g. Salvia divinorum), and classic psychedelics (e.g. LSD, psilocybin), in the form of a "bad trip".
Psychoactive drug misuse, dependence and addiction have resulted in legal measures and moral debate. Governmental controls on manufacture, supply and prescription attempt to reduce problematic medical drug use. Ethical concerns have also been raised about over-use of these drugs clinically, and about their marketing by manufacturers. Popular campaigns to allow certain recreational drug use (e.g. cannabis) are also ongoing.

More about Psychoactive Drugs
Browse All Tags